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Summary
Objective: In idiopathic chondrocalcinosis and in osteoarthritis (OA), increased extracellular PPi (ecPPi) promotes calcification. In
chromosome 5p-associated familial chondrocalcinotic degenerative arthropathy, certain mutations in the membrane protein ANK may
chronically raise ecPPi via enhanced PPi channeling. Therefore, we assessed if dysregulated wild-type ANK expression could contribute to
pathogenesis of idiopathic degenerative arthropathy through elevated ecPPi.
Design: Using cells with genetic alterations in expression of ANK and the PPi-generating nucleotide pyrophosphatase phosphodiestrase(NPP) PC-1, we examined how increased ANK expression elevates ecPPI, testing for codependent effects with PC-1. We also evaluated the
effects of ANK expression on chondrocyte growth, matrix synthesis, and MMP-13 expression and we immunohistochemically examined ANK
expression in situ in human knee OA cartilages.
Results: Using cells expressing defective ANK, as well as PC-1 knockout cells, we demonstrated that ANK required PC-1 (and vice versa)
to raise ecPPi and that the major ecPPi regulator TGF required both ANK and PC-1 to elevate ecPPi. Upregulation of wild-type ANK by
transfection in normal chondrocytes not only raised ecPPi 5-fold to ∼100 nM but also directly stimulated matrix calcification and inhibited
collagen and sulfated proteoglycans synthesis. In addition, upregulated ANK induced chondrocyte MMP-13, an effect that also was
stimulated within 2 h by treatment of chondrocytes with 100 nM PPi alone. Finally, ANK expression was upregulated in situ in human knee
OA cartilages.
Conclusion: Elevation of ecPPi by ANK critically requires the fraction of cellular PPi generated by PC-1. The upregulation of ANK expression
in OA cartilage and the capacity of increased ANK expression to induce MMP-13 and to promote matrix loss suggest that increased ANK
expression and ecPPi exert noxious effects in degenerative arthropathies beyond stimulation of calcification.
© 2003 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Introduction
A major mechanism by which chondrocytes prevent
articular cartilage from calcifying is by maintaining physio-
logic extracellular levels of the potent basic calcium phos-
phate (BCP) crystal deposition inhibitor PPi.1. However,
substantial increases in cartilage PPi generation that result
in sustained elevation of extracellular PPi (ecPPi) in thejoint occur in association with cartilage aging and with
idiopathic, metabolic, and certain familial forms of chondro-
calcinosis, as well as in many subjects with OA1–6. Over
time, this circumstance stimulates pathologic calcifica-
tion with calcium pyrophosphosphate dihydrate (CPPD)
crystals, a common problem that can manifest with sub-
stantial intra-articular inflammatory changes and clinical
symptoms1,5,6. Hydrolysis of excess PPi also paradoxically
promotes cartilage BCP crystal formation in degenerative
joint disease via elevated Pi generation1,3,7.
PPi is generated both as a by product of numerous
biosynthetic reactions and through hydrolysis of ATP and
other nucleoside triphosphates (EC 3.6.1.8) by nucleotide
pyrophosphatase phosphodiesterase (NPP) ecto-
enzymes3,7. Importantly, intra-articular NPP activity
increases concordantly with PPi generation in a donor
age-dependent manner linked to idiopathic chondro-
calcinosis in human knees3,4,6,8. Three distinct NPP iso-
enzymes (NPP1-3) are expressed in bone and cartilage,
and PC-1 (NPP1) and B10 (NPP3) both catalyze intra-
cellular PPi generation3,9,10. However, B10/NPP3 does not
appear to directly promote ecPPi elevation in skeletal
cells3,9,10. In contrast, studies using osteoblasts and
fibroblasts genetically deficient in the NPP isoenzyme
PC-1 have revealed that PC-1-induced PPi generation is
required to support 35–50% of the ecPPi levels maintained
by these cell types11,12. Furthermore, upregulation of PC-1
(but not other NPP isoenzymes) has been directly linked
with calcification by chondrocytes in situ and in vitro3.
The regulatory balance for ecPPi levels between gener-
ation of PPi and pyrophosphatase-catalyzed PPi hydrolysis
is complemented by cellular channeling of intracellular PPi(icPPi) to the exterior involving the multiple-pass trans-
membrane protein ANK7,13–15. In this context, transfection
of wild type ANK decreases icPPi and elevates ecPPi
concentrations in normal fibroblasts13. But homozygosity
for a naturally occurring truncation mutation of the putative
C-terminal ANK cytosolic domain in ank/ank mice appar-
ently causes ‘loss of function’ of ANK, with consequent
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elevation of icPPi and depression of ecPPi13. Significantly,
ank/ank mice develop OA associated with cartilaginous
BCP crystal deposition, as well as widespread hyper-
ostosis13, a phenotype remarkably similar to that of PC-1
deficient mice12,16.
Two investigative groups recently identified linkages of
familial CPPD deposition arthropathy to certain autosomal
dominant mutations in the ANKH gene for the human
homologue of ANK on chromosome 5p13,17. Preliminary
studies suggested that subtle ‘gain of function’ of certain
ANK mutants might increase chondrocyte ‘leakiness’ for
‘PPi’ in 5p familial chondrocalcinosis13. Functionally signifi-
cant ANK mutation appears to be rare in sporadic chondro-
calcinosis13. But ANK expression, like PC-1 expression18,
is subject to regulation in vitro by certain growth factors and
cytokines that modulate ecPPi levels19. These include
TGF, a major promoter of elevated ecPPi6,9,18. Further-
more, ANK mRNA levels were increased in cultured
chondrocytes from cartilages with OA and chondrocalcino-
sis relative to normal cartilages when the cells were studied
48 h following extraction19.
Our objectives in this study were to first ascertain how
ANK raises ecPPi, by testing for a mechanism dependent
on the fraction of PPi generation attributable to PC-1.
Because PPi modulates not only calcification but also
biosynthetic reactions and expression of osteopontin
mRNA and possibly other genes in osteoblasts20, our
second objective was to test for the potential of upregulated
ANK to modify chondrocyte function and promote degen-
erative arthropathy. Our last objective was to assess for
upregulated ANK expression in situ in OA cartilage.
Materials and methods
REAGENTS
Human recombinant TGF 1 and IL-1 were obtained
from R&D Systems (Minneapolis, MN). All chemical
reagents were obtained from Sigma (St Louis, MO), unless
otherwise indicated.
ISOLATION, CULTURE, AND TRANSFECTION OF PRIMARY
CALVARIAL OSTEOBLASTS FROM ANK/ANK AND PC-1/NPP1 NULL
MICE
The ank/ank and PC-1/NPP1 null mice colonies
employed and methods for breeding, use of congenic
control normal mice, and genotype screening were as
described in detail20. Primary cultures of osteoblasts were
isolated from calvariae of 0–3 day-old pups (congenic PC-1
+/+ and PC-1 −/−, congenic ANK/ANK and ank/ank mice)
by sequential collagenase digestion, as described20. An
enriched cell population of osteoblastic phenotype obtained
from the last five collagenase isolations was pooled and
seeded at a density of approximately 4×104 cells/cm2 in
-MEM (Gibco-BRL, Grand Island, NY), containing 10%
heat inactivated FCS, glutamine (2 mM), penicillin
(50 U/ml) and streptomycin (0.5 mg/ml). Transfection
studies in osteoblasts were performed using Lipofectamine
Plus (Life Technologies, Grand Island, NY) as described20,
with >40% transfection efficiency verified via control
-galactosidase transfection. We used cDNA expression
constructs in pcDNA3.1 for wild-type human PC-120 and for
murine wild-type ANK and the ank mutant ANK (designated
as ANK, and MUT ank, respectively in the Figures)13, which
were provided by Dr David Kingsley (Stanford University,
Palo Alto, CA).
ISOLATION, CULTURE, AND TRANSFECTION OF BOVINE ARTICULAR
CHONDROCYTES
Articular chondrocytes from normal bovine knees of
mature animals of 30–60 months age (Animal Tech-
nologies, Tyler, TX) were obtained by dissection and diges-
tion of the tibial plateau and femoral condyle articular
cartilage (using 2 mg/ml of collagenase, incubated at 37°C
for 18 h), as previously described21. We excluded speci-
mens containing fractures, cartilage fibrillation or cartilage
erosion. The typical yield of chondrocytes was ∼50 million
per normal bovine knee. Primary chondrocytes were cul-
tured in DMEM high glucose supplemented with 10% FCS,
1% glutamine, 100 U/ml Penicillin, 50 µg/ml Streptomycin
(Omega Scientific, Tarzana, CA) and maintained at 37°C in
the presence of 5% CO2 for 7 days following collagenase
digestion, prior to initiation of each experiment. All func-
tional studies of chondrocytes were performed in DMEM
high glucose supplemented with 1% FCS, 1% glutamine,
100 U/ml Penicillin, 50 µg/ml Streptomycin (Medium A)
unless otherwise stated. For transfection studies, aliquots
of primary bovine articular chondrocytes (4×105 cells each)
were plated in 60 mm dishes, allowed to adhere, and then
transfected with the indicated constructs using a described,
validated Fugene 6/hyaluronidase method with >40%
transfection efficiency verified via control -galactosidase
transfection21. Following transfection, 1×105 cells/well were
transferred to polyHEME coated wells of 96-well plates for
studies using non-adherent culture in medium supple-
mented with 50 µg/ml of ascorbate, as described21.
ASSESSMENT OF MATRIX CALCIFICATION
To quantify matrix calcification by the primary bovine
articular chondrocytes, we used a previously described
Alizarin Red S binding assay, which was further validated in
each experiment by direct visual observation of Alizarin
Red S staining in each plate3. In brief, following transfec-
tion, bovine chondrocytes (1×105 cells/well) were cultured
in a 96 well plate coated with polyHEME in 1% FCS, 1%
glutamine, 100 U/ml Penicillin, 50 µg/ml Streptomycin,
1 mM sodium phosphate and 50 µg/ml of ascorbate21. At
10 days, the dishes were stained with Alizarin Red S and
quantified for µmol of bound Alizarin Red S per µg DNA in
each well, as described21.
PPI AND RELATED ASSAYS
PPi concentrations were determined by differential
adsorption on activated charcoal of UDP-D-[6-3H] glucose
(Amersham, Chicago, IL) from the reaction product
6-phospho [6-3H] gluconate9. Samples were prepared for
analyses of icPPi and ecPPi, and PPi concentrations were
equalized for the DNA concentration in each well, as
described9. We determined specific activity of NPP by
colorimetric assay using p-nitropheylthymidine mono-
phosphate as the substrate at alkaline pH9. Alkaline
phosphatase (AP) specific activity also was determined
colorimetrically9. One Unit of NPP (or AP) was defined as
one µmole of substrate hydrolyzed per hour (per µg protein
in each sample).
ASSAYS OF COLLAGEN AND PROTEOGLYCANS (PG) SYNTHESIS
PG and collagen synthesis were quantified as described
in detail22. In brief, to assay PG synthesis, aliquots of 1×105
cells were plated in wells of 96 well plates coated with
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polyHEME. The cells were cultured for 48 h in the presence
of 20 µCi/ml of [35S] sodium sulfate in the culture medium
described above. Conditioned media and cell extracts were
then collected and fractionated using a Sephadex G-25M
PD-10 column (Amersham Pharmacia, Piscataway, NJ),
with elution using 4 M guanidine HCl22. We used 3H Proline
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Fig. 1. Requirement for both ANK and PC-1 in TGF-induced elevation of ecPPi. Primary calvarial osteoblasts from ANK/ANK and ank/ank
mice (panel A) or from PC-1 (+/+) and PC-1 (−/−) mice (panel B) were stimulated in monolayer culture (3×105 cells/well in a 6-well culture
dish) for 48 h with 10 ng/ml of TGF in  MEM medium supplemented with 1% FCS. The cell lysates and conditioned media were collected
and analyzed for ecPPi and icPPi, respectively, normalized for cell DNA as described in the Methods. Each assay was run in triplicate and
5 mice of each genotype were studied. *P<0.05.
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incorporation into protein sensitive to 80 U/ml crude colla-
genase (Worthington Biochemical, Lakewood, NJ) to quan-
tify collagen synthesis22. Aliquots of 1×105 transfected
chondrocytes on polyHEME-coated wells were cultured for
48 h, after which 1 µCi/ml of 3H Proline was added and
cells grown for another 24 h. Conditioned media then were
collected and precipitated with 15% trichloroacetic acid
(TCA), and after repeated washing, the relative amounts of
3H Proline incorporation into collagenase-sensitive protein
and total protein were determined. Results for collagen
synthesis were expressed as collagenase-sensitive cpm/µg
of protein.
ANALYSES OF MMP-13 BY RT-PCR, SDS-PAGE/WESTERN BLOTTING,
AND FLUOROGENIC SUBSTRATE ACTIVITY ASSAY
For RT-PCR, total RNA was isolated using TriZOL
(Invitrogen, San Diego, CA) and reverse-transcribed and
amplified for 35 cycles as described3. To assess for MMP-
13, forward (5′-CTTCCTCTTCTTCAGCTGGAC-3′) and
reverse (5′-ATGTATTCACCCACATCAGG- 3′) primers
were used23, and primers for the ribosomal ‘housekeeping
gene’ L30 were as previously described21.
SDS-PAGE/Western blotting studies employed pre-
viously described methods, in which aliquots (0.01 mg) of
protein from each sample were separated by SDS-PAGE
under reducing conditions and transferred to nitrocellu-
lose21. Conditioned media were collected and concentrated
with 15% TCA. Anti-MMP-13 (Chemicon, Temecula, CA)
antibodies were used at 1:1000 dilution in Western blotting,
with immunoreactive products detected using an enhanced
chemiluminesence system (Pierce, Rockford, IL), after
incubation with horseradish peroxidase-conjugated sec-
ondary antibody in blocking buffer for 1 h.
The fluorogenic substrate assay for MMP-13 activity
employed aliquots of 1×105 primary bovine chondrocytes
plated in flat bottom 96 well plates, from which conditioned
media were collected. To assay MMP-13 activity, aliquots
of 50 µl conditioned media were added to individual wells
in a 96-well plate containing 25 µM of the specific
MMP-13 fluorogenic substrate MCA-Pro-Cha-Gly-Nva-
His-Ala-Dpa-NH2 (Cha=L-cyclohexylalanine; Dpa=3-(2,4-
dinitrophenyl)-L-2,3-diaminopropionyl; Nva=L-norvaline)
(Calbiochem) in 50 µl of 200 mM NaCl, 50 mM Tris-HCl,
5 mM CaCl2, 20 µm ZnSO4, and 0.05% BRIJ 35, pH 7.5 for
18 h at 37°C. Fluorescence was read at excitation 325 nm,
emission 393 nm.
HISTOLOGY AND IMMUNOHISTOCHEMISTRY
Specimens of normal and degenerative human articular
cartilage were taken as full thickness blocks and graded
for OA on a scale of I-IV as previously described8. For
immunohistologic analysis of ANK, frozen sections (5 µm
thick) were incubated with 0.5 mg/ml hyaluronidase for
15 min at 37°C, blocked with 10% goat serum for 20 min
and incubated for 4 h at 4°C with rabbit anti-ANK 3 poly-
clonal antibody to ANK13, also generously provided by Dr.
Kingsley. Washed sections were incubated for 1 h at 23°C
with biotinylated goat anti-rabbit IgG followed by 1 h incu-
bation with peroxidase-conjugated avidin. Peroxidase
activity was detected using the Sigma Fast DAB staining
kit, according to manufacturer instructions.
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Fig. 2. Validation of functionally efficient transfection of primary osteoblasts with the NPP isoenzyme PC-1. Primary calvarial osteoblasts from
ANK/ANK and ank/ank mice in monolayer culture (3×105 cells/well in a 6-well dish) were transiently transfected with PC-1 cDNA as
described in the Methods. After 48 h, the cell lysates were collected and the samples analyzed for NPP activity, with assays run in triplicate
and 5 mice of each genotype studied. *P<0.05.
324 K. Johnson and R. Terkeltaub: ANK in Osteoarthritis
STATISTICS
Where indicated, error bars represent SD. Statistical
analyses were performed using the Student’s t-test (paired
2-sample testing for means), and, where indicated,
additionally by ANOVA.
Results
ANK AND PC-1/NPP1 CO-ORDINATELY PROMOTE ECPPI ELEVATION
We examined ANK function in vitro, first focusing on how
upregulation of ANK modulates ecPPi. Because of the
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Fig. 3. Co-dependence of ANK and PC-1 in the induction of elevation of ecPPi. Primary calvarial osteoblasts from ANK/ANK (panel A),
ank/ank mice (panel B), PC-1 (+/+) (panel C), or PC-1 (−/−) mice (panel D) were transfected with PC-1, and wild-type (WT) ANK and mutant
(MUT) ank, as described above. After 48 h, the conditioned media and cell lysates were collected, heat-inactivated, and analyzed for ecPPi
and icPPi as described above, with assays run in triplicate. Ten mice of each genotype were studied. *P<0.05 by ANOVA and Student’s
t-test.
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remarkably similar phenotypes of ank/ank and PC-1/NPP1-
deficient mice13,16,20, we tested the hypothesis that ANK
promotes elevation of ecPPi in a co-ordinated manner
involving the fraction of cellular PPi generated by PC-1.
First, we used PC-1 (−/−) and ank/ank cells and their
respective congenic wild-type (WT) controls. Because of
inherent technical limitations in obtaining adequate num-
bers of purified mouse chondrocytes for these studies, we
examined primary calvarial osteoblasts. The ecPPi levels
were approximately 50% lower in PC-1 (−/−) cells and
ank/ank cells than in respective congenic controls (Fig. 1).
We demonstrated that TGF, a major inducer of ecPPi
elevation in cultured chondrocytes and osteoblasts4,6,7,9,
failed to significantly increase ecPPi in the absence of
either normal ANK or PC-1 expression, in contrast to
significantly increased ecPPi induced by TGF in respec-
tive congenic WT primary mouse osteoblast controls (Fig.
1). Next, using the same general approach, we assessed
whether ANK-induced elevation of ecPPi required PC-1
and vice versa. In doing so, we employed transient trans-
fection of osteoblasts under conditions previously validated
to be efficient20. We achieved greater than doubling of NPP
enzyme activity in both ank/ank and WT (ANK/ANK) cells
by transient PC-1 transfection (Fig. 2). Under these con-
ditions, transfection of PC-1 failed to increase ecPPi in
ank/ank cells, but did so in ANK/ANK cells (Fig. 3, Panels B
and A, respectively). Tranfection of ANK significantly in-
creased ecPPi, whereas transfection of the mutant ank,
which lacks the ANK C-terminal cytosolic domain13, signifi-
cantly increased icPPi in normal (PC-1+/+) cells (Fig. 3C).
However, neither ANK nor ank significantly altered icPPi
or ecPPi in PC-1(−/−) cells (Fig. 3D). Therefore, ANK
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regulated PPi levels in a manner coordinated with PPi-
generating activity specifically contributed by PC-1.
FUNCTIONAL EFFECTS IN CHONDROCYTES OF UPREGULATION OF
ANK EXPRESSION VIA ECPPI
We next examined the in vitro functional consequences
of upregulated ANK expression in chondrocytes. We
focused on potential effects promoting OA and chondro-
calcinosis and the relationship of such ANK-mediated
chondrocyte responses to elevation of ecPPi. To do so, we
cultured primary normal bovine knee articular chondrocytes
under nonadherent conditions using polyHEME-coated
surfaces. In addition, we directly upregulated expression of
ANK and pertinent controls via a transient transfection
approach21. To validate our experimental conditions, we
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Fig. 4. C and D.
Fig. 4. Effects of transfection of ANK on PPi levels in primary bovine chondrocytes. Primary bovine chondrocytes were cultured under
nonadherent conditions (1×105 cells/well in a 96 well plate coated with polyHEME) following transient transfection with cDNA constructs as
indicated, using Fugene 6/hyaluronidase as described in the Methods. The cells were incubated for 48 h at 37°C in medium supplemented
with 1% FCS and 50 µg/ml of ascorbate, as described in the Methods. Data were pooled from 6 experiments, each performed in triplicate.
Panels A, B: The cell lysates were collected in 1.6 mM MgCl2, 0.2 M Tris, pH 8.1, and 1% Triton X-100 and then assayed for NPP and AP
specific activity, as described in the Methods. Panel C: The cell lysates were collected and the icPPi levels were determined and normalized
for cellular DNA, as described above. Panel D: The conditioned media were collected and analyzed for ecPPi, with results expressed here
as molar concentration of ecPPi. *P<0.05 by ANOVA and Student’s t-test.
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verified that PC-1 transfection, but not transfection of the
ANK or the ank mutant, markedly elevated NPP specific
activity in the primary chondrocytes (Fig. 4A).
Next, we assessed ecPPi and icPPi under these con-
ditions, in which transfection of PC-1, ANK, and ank did not
significantly affect the specific activity of the major chondro-
cyte PPi-degrading ecto-enzyme AP (Fig. 4B). We also
validated that direct upregulation of ANK significantly
decreased icPPi, with the opposite effects stimulated by
forced ank expression and PC-1 expression in the primary
chondrocytes (Fig. 4C). ANK and PC-1 both were con-
firmed3,9,13 to induce increased ecPPi levels. The concen-
trations of ecPPi transfected with ANK and PC-1 went up by
approximately 5-fold to reach ∼100 nM for the chondro-
cytes (Fig. 4D). Under these conditions, sulfated PG syn-
thesis and collagen synthesis in chondrocytes were
suppressed by ANK but augmented by ank transfection
(Fig. 5A,B). In chondrocytes carried for a substantially
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Fig. 5. Transfection of ANK and ank alter sulfated PG and collagen synthesis in chondrocytes in opposing directions. For studies of PG
synthesis in Panel A, primary bovine chondrocytes, cultured in nonadherent conditions (1×105 cells/well in a 96 well plate coated with
polyHEME) following transfection, were incubated in triplicate for 48 h at 37°C in 1% stimulation medium containing 20 µCi/ml of [35S]
sodium sulfate and 50 µg/ml of ascorbate for 48 h. The conditioned media and cells were collected, extracted and eluted from Sephadex
G-25M PD-10 columns. Panel B: Primary bovine chondrocytes, cultured in nonadherent conditions (1×105 cells/well in a 96 well plate coated
with polyHEME) following transfection, were incubated for 72 h at 37°C in medium supplemented with 1% FCS. During the last 24 hours,
1 µCi/ml of 3H Proline was added to the media. The media were collected and precipitated with 15% TCA and the ratio of 3H incorporated
into collagenase sensitive protein relative to total protein used to calculate collagen synthesis, expressed as cpm/µg of protein, as described
in the Methods. Experiments were run in replicates of 3, with data compiled from 5 experiments. *P<0.05.
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longer period (10 days), the upregulated expression of ANK
induced more than doubling of matrix calcification (Fig. 6).
In contrast, transfection of ank did not significantly affect
matrix calcification within this time frame (Fig. 6).
Because MMP-13 is a central regulator of matrix degra-
dation in OA24, we next studied and compared the effects
of ANK and ank transfection in primary chondrocytes on
expression and activity of MMP-13. Under conditions
where 24 h of positive control IL-1 treatment induced
MMP-13 mRNA, ANK (but not ank or TGF) also induced
MMP-13 mRNA expression (Fig. 7A). At 7 days, some full
length MMP-13 pro-enzyme was detectable by SDS-PAGE/
Western blotting in the conditioned media of all cells. But
detection of a lower molecular weight activation band of
MMP-13 was unique to the media of cells treated with IL-1
or transfected with ANK (as opposed to cells transfected
with ank) (Fig. 7B). As measured by specific fluorogenic
substrate assay, conditioned media MMP-13 activity rose,
but only modestly so, with IL-1-treatment (Fig. 7). ANK
transfection induced relatively marked MMP-13 activity
(Fig. 7C).
Given the distinct effects of ANK and ank on both ecPPi
and MMP-13 (Fig. 7A), we next tested if increased ecPPi
played a direct role in effects of ANK on MMP-13 (Fig. 8).
To do so, we pulsed chondrocytes with exogenous PPi(10 nM to 10 µM) for 2 h. We observed rapid induction of
MMP-13 mRNA in chondrocytes treated with ≥100 nM PPi(Fig. 8).
UPREGULATED ANK EXPRESSION IN SITU IN HUMAN KNEE OA
CARTILAGE
In view of the deleterious responses of chondrocytes to
upregulated ANK in vitro, we next evaluated for upregu-
lated ANK expression in OA cartilage in situ. Constitutive
ANK expression was detectable in normal human knee
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Fig. 6. Transfection of ANK increases matrix calcification in primary
bovine chondrocytes. Following transfection, primary bovine
chondrocytes were plated (1×105 cells/well) in individual wells
of 96 well plates previously coated with polyHEME. The cells
were cultured in media supplemented with 1% FCS, 50 µg/ml of
ascorbate and 1 mM sodium phosphate, as described in the
Methods. Calcification was measured at 10 days by binding of
insoluble Alizarin Red S, as described in the Methods, with each
experiment run in replicates of eight and the data pooled from four
separate experiments. *P<0.05.
Fig. 7. Upregulated expression of WT ANK induces increased
MMP-13 expression and activity. Panel A. Following transfection
with vector DNA alone or the indicated cDNA constructs in the
same vector, primary bovine chondrocytes were cultured in mono-
layer (3×105 cells/well in a 6 well dish) for 24 h. Where indicated,
IL-1 or TGF (10 ng/ml) were added to vector control-transfected
cells. The total RNA was collected and reversed transcribed
as described in the methods. Thirty-five cycles of PCR were
performed for MMP-13 and the housekeeping protein L30.
Panel B. Following transfection with vector control or the indicated
cDNA constructs in the remaining samples, primary bovine
chondrocytes were in cultured in monolayer (3×105 cells/well in a
6-well dish) for 7 days. Where indicated, IL-1 or TGF (10 ng/ml)
were added to vector control-transfected cells. The conditioned
media were collected, concentrated and aliquots of 0.01 mg were
separated by SDS-PAGE and studied for MMP-13 by Western
blotting, as described in the Methods. The higher molecular
immunoreactive MMP-13 bands represent pro-enzyme and the
lower molecular weight immunoreactive bands represent poten-
tially activated enzyme. Panel C. Following transfection and treat-
ments as described in Panel B above, primary bovine
chondrocytes were cultured in monolayer (3×105 cells/well in a 6
well dish) for 7 days. The conditioned media were collected and
analyzed for MMP-13 activity per cell number via assay for
cleavage of a fluorogenic substrate specific for MMP-13, with each
experiment run in replicates of three and data pooled from 5
separate experiments. *P<0.05.
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cartilages at a low level and predominantly in chondrocytes
of the superficial zone, with substantially less intense
ANK expression detected in the middle and deep zones
(Fig. 9A). Detection of robust ANK expression in all zones
of knee cartilage was a feature of OA, with Fig. 9B-C
demonstrating representative stained sections from sub-
jects with grades II and III cartilage lesions. Therefore, ANK
expression was upregulated throughout OA cartilages
in situ.
Discussion
The basic mechanisms for the strong associations of
elevated intra-articular ecPPi with articular cartilage aging
and various degenerative arthropathies1–6 have been sub-
ject to re-evaluation in light of recent findings. Specifically,
results of prior studies on cartilage explants or chondro-
cytes treated with supraphysiologic exogenous ATP, or
trypsinized to nonspecifically cleave membrane proteins,
were interpreted to indicate that elevated ecPPi levels in
cartilage principally arises from extracellular ATP hydrolysis
by NPP ecto-enzyme activity resident on the plasma
membrane25–28. But this paradigm has subsequently been
called into question. In specific, the anion transport inhibitor
probenecid at millimolar concentrations not only inhibited
TGF-induced ecPPi elevation29 but also inhibited the
capacity of ANK to elevate ecPPi13. Altered function of at
least one mutant form of ANK, a promoter of intracellular
PPi channeling to the cell exterior, also appeared to
increase chondrocyte ‘leakiness’ for PPi in autosomal
dominant chromosome 5p-linked familial chondrocalcino-
sis15.
The results of this study further supported a central role
of icPPi to ecPPi channeling by ANK in the modulation of
ecPPi by skeletal cells. Specifically, we analyzed how
normal ANK functions to elevate ecPPi using recombinant
ANK and primary osteoblasts with genetically mediated
alterations in PPi generation and transport. By transfecting
ANK, we determined that ANK elevated ecPPi in a manner
dependent on PC-1 NPP activity. Correspondingly, trans-
fection of the ank mutant failed to elevate icPPi in PC-1(−/−) cells. In addition, ank appeared to exert a ‘dominant
negative’ effect on intracellular to extracellular PPi move-
ment in normal cells transfected with ank.
TGF, which becomes upregulated in OA cartilage30,
exerts profound effects on ecPPi levels in chondrocytes
and osteoblasts20,31. In this study, both PC-1 and ANK
were critical for ecPPi elevation induced by TGF . Further-
more, TGF induces both PC-118 and ANK expression19,
and TGF stimulates the translocation of NPP activity to
the plasma membrane and into plasma membrane-derived
matrix vesicles9,18,32. The results of this study suggest that
the intracellular fraction of PPi made by PC-1, which
accounted for ∼50% of icPPi in primary osteoblasts, is the
principal PPi fraction channeled to the cell exterior by ANK.
The results also suggest that the channeling by ANK of the
icPPi fraction generated by PC-1 is subject to upregulation
by TGF. Because the ecto-enzyme activity of transmem-
brane full-length PC-1 would be expected to generate PPi
intracellularly only within the lumen of organelles9, our
findings raise compelling questions about how PC-1 and
ANK co-ordinate to raise ecPPi. For example, it remains to
be determined if ANK modulates transport of the NPP
substrate ATP, if ANK and PC-1 co-localize intracellularly,
and if ANK can channel PPi generated by PC-1 in the
endoplasmic reticulum or in the Golgi or transport vesicles
that deliver PC-1 to the plasma membrane9,33. Alterna-
tively, soluble forms of proteolytically released PC-1 are
known to be generated34, and intracellular generation of
soluble PC-1 might provide a source of cytosolic icPPi for
plasma membrane ANK to channel to the extracellular
space.
The results of this study reinforced the major effects of
ANK and PC-1 on PPi metabolism in chondrocytes. How-
ever, ANK nor PC-1 are not the sole determinants for the
levels of either ecPPi or icPPi, due to concurrent effects
of factors including substrate availability, certain NPP
family isozymes other than PC-1, pyrophosphatases and
ATPases, and the effects of various cytokines, growth
factors, and matrix proteins3,6,7,9,10,12,18,21,22,25,26,28,29,31.
Indeed, icPPi can be substantially reflective of the pools of
PPi in the mitochondrion and endoplasmic reticulum as well
as cellular biosynthetic activities7 and icPPi appears to
fluctutate more than ecPPi in osteoblasts (Johnson K, et al,
unpublished observations). As such, cell metabolic effects
following on transfection conditions, which included adding
DNA and performing lipofection for 6 h in low serum con-
ditions, likely accounted for the nearly equal icPPi levels in
wild type and ank/ank primary osteoblasts seen here. In a
separate study, we have confirmed elevation of icPPi and
depression of ecPPi in untransfected ank/ank mouse
primary osteoblasts20, analagous to findings in mouse
fibroblasts13.
In this study, we demonstrated upregulated ANK expres-
sion in situ in human knee OA cartilages. A failure of matrix
Fig. 8. PPi excess rapidly induces MMP-13 expression. Primary
bovine chondrocytes were in cultured in monolayer (3×105 cells/
well in a 6 well dish) for 2 h in the presence of the indicated
concentrations of PPi achieved by direct supplementation of the
media with sodium PPi. At 2 h, total RNA was collected and
reversed transcribed, as described above, for RT-PCR analyses of
MMP-13 and L30. Indicated in the lower part of the Figure are the
results of densitometric analyses of the RT-PCR data for the ratio
of the MMP-13 mRNA relative to the respective L30 mRNA control.
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synthesis to keep up with matrix degradation is a feature of
OA35,36. Our results suggest that in the setting of OA,
upregulated ANK expression may be one of the factors
contributing to a failure of cartilage tissue repair. Specifi-
cally, we observed that direct upregulation of ANK expres-
sion in chondrocytes by transfection in vitro not only
promoted calcification but also impaired chondrocyte
matrix homeostasis. The direct upregulation of ANK
induced suppression of both collagen and PG synthesis
in chondrocytes. These effects occurred several days in
advance of augmented calcification, which requires at least
a week to develop in this experimental system3. Further-
more, transfection of ank induced effects opposite to those
of ANK, as ank induced increased synthesis of collagen
and PG synthesis under the same conditions, without
causing a significant change on matrix calcification in
chondrocytes. As such, the deleterious effects of upregu-
lated ANK expression on matrix synthesis did not appear to
be artifacts from either the transfection of chondrocytes or
the capacity of ANK to promote calcification. Indeed, we
also have observed significantly increased collagen syn-
thesis in ank/ank and PC-1 (−/−) primary mouse osteo-
blasts relative to their respective normal control congenic
osteoblasts (Johnson, K et al., unpublished observations).
The precise mechanism by which ANK and ank opposingly
regulate collagen biosynthesis is not clear, but their con-
trasting effects on ecPPi are strong candidates to be
centrally involved.
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In this study, we observed that upregulated ANK expres-
sion not only impaired matrix synthesis but also induced
MMP-13 mRNA expression and, with time, promoted a
striking increase in MMP-13 activity. Significantly, the
forced upregulation of ANK induced nearly a 5-fold rise in
ecPPi, such that chondrocyte ecPPi levels reached the
100 nM range in vitro. We further observed that pulsing of
chondrocytes with >100 nM exogenous PPi induced
MMP-13 expression at 2 h of treatment time. Such absolute
concentrations of ecPPi seen with cultured chondrocytes in
this study are lower than those reported to be sustained on
a chronic basis in vivo in chondrocalcinosis joint fluids and
to be achieved in vitro in a variety of other studies of
cartilages or isolated chondrocytes2,5,6,28,29. But it should
be noted that chondrocytes were examined under con-
ditions of supplementation with only 1% serum and under a
limited set of culture conditions in our study. Despite such
limitations in extrapolating data to biologic conditions
in vivo, we believe the novel demonstration of rapid and
direct noxious effects for chondrocytes of relative change in
ecPPi levels of ∼5-fold is noteworthy. Furthermore, the
evidence that upregulation of both ANK and exogenous
PPi rapidly promote MMP-13 expression identify potential
effects on chondrocytes of augmented ecPPi by itself that
ultimately promote OA. More extended incubation of
chondrocytes with exogenous PPi was beyond the techni-
cal scope of this study, as it requires conditions optimized
and validated for generation of sustaining of ecPPi
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elevation at specific levels by such treatment. We have
observed no changes in nitric oxide generation in chondro-
cytes in which ANK is directly upregulated (Johnson, K,
et al., unpublished observations). Thus, the effects of ANK
on MMP-13 activity are not attributable to nitric oxide, which
is known to promote activation of certain MMPs via
S-nitrosylation37. It remains to be determined if ecPPi could
directly modulate proteolytic cleavage and activation of the
formed MMP-13 pro-enzyme. In this study, we examined
articular chondrocytes in vitro under culture conditions
where formation of the BCP crystal hydroxyapatite is mark-
edly favored3. Detailed studies to physically characterize
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Fig. 9. Detection of ANK expression in situ by immunohistochemistry in normal and OA human articular cartilages. To detect ANK, sections
of 5 µm thickness from normal and OA human knee cartilages were stained using polyclonal anti-ANK antibody for 4 h at 4°C followed by
incubation with a biotinylated goat anti-rabbit IgG and peroxidase-conjugated avidin, as described in the Methods. For negative staining
controls, we used a 1:100 dilution of nonimmune rabbit serum in place of the primary antibody. Panel A shows the analysis of normal
cartilages from a normal donor, representative of three studied. Panels B and C are analyses of OA knee cartilages from different donors with
grade III and grade IV disease respectively, and the increased intensity of ANK expression (relative to normal cartilages) is representative
of five OA knee cartilage donors studied. Magnifications in panels: Superficial Zone, 625X; Middle Zone, 625X; Overview and Negative
Staining Control, 150X.
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the crystals induced to deposit by upregulated wild type
ANK expression will be of interest using intact normal
cartilages and cartilages with matrix changes related to
aging and degenerative arthritis. The noxious pro-
inflammatory effects of CPPD and BCP crystal deposition
in articular cartilages are well-recognized and promote
progression of degenerative joint disease38,39. The results
of this study impart pathophysiologic significance to elev-
ation of cartilage ecPPi in degenerative arthropathies that
goes beyond promotion of pathologic cartilage calcification.
As such, the clinical terminology ‘pyrophosphate arthro-
pathy’ used to describe chronic cartilage degenerative
disease associated with CPPD crystal deposition40
appears to appropriately describe a central feature in
pathogenesis. The demonstration of ‘gain-of- function’ of
ANK in idiopathic OA, superimposed on recent findings
consistent with ‘gain-of- function’ of ANK in the degener-
ative arthropathy familial chromosome 5p chondro-
calcinosis15, indicates that inhibition of ANK-mediated PPi
channeling provides a novel site for potential therapeutic
intervention in certain degenerative arthropathies.
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